Skip to content

A study evaluating the route of administration of dexmedetomidine and dexamethasone in local anaesthetic in patients receiving nerve block for upper limb surgeries.

EFFECT OF DEXMEDETOMIDINE AND DEXAMATHASONE ADMINISTRATION ROUTE AS LOCAL ANAESTHETIC ADJUVANT IN BRACHIAL PLEXUS BLOCK A THREE ARM RANDOMISED STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088951
Enrollment
60
Registered
2025-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Three arm parallel study Group 1: Perineural dexmedetomidine 5 mcg plus Intravenous dexamethasone 8 mg Intervention2: Three arm parallel study Group 2: Perineural dexamethasone 8 mg pl

Sponsors

Pravin K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists ASA physical status I II or III who were scheduled for elective upper extremity surgery under supraclavicular BPB Both elective and emergency surgeries

Exclusion criteria

Exclusion criteria: Contraindication for BPB Refusal to consent severe coagulopathy sepsis infection at the block site Preexisting neuropathy of the surgical limb Pregnancy BMI more than 35 kg per m2 Patient on an alpha agonist as a hypertensive medication Uncontrolled Diabetes Mellitus RBS more than 250 mg per dl Actual body weight less than 40 kg

Design outcomes

Primary

MeasureTime frame
Primary outcome: Duration of analgesia time between block completion and the first request for analgesic supplementation Timepoint: Primary outcome: Duration of analgesia time between block completion and the first request for analgesic supplementation Secondary outcomes 1Includes motor block duration defined as the time between block completion and complete resolution of the motor block; a score of 2 in the 3-point modified Bromage score 2.The duration of sensory blockade is defined as the time between block completion (withdrawal of block needle) and resolution of sensory block (Temperature) at the dermatomal level of C5). 3.Sensory block onset (time between block completion and sensory block (Temperature) at the dermatomal level of C5). 4.Motor block onset (time between block completion and achieving score of 1 in 3-point modified Bromage Scale);

Secondary

MeasureTime frame
Secondary outcomes 1 Includes motor block duration defined as the time between block completion and complete resolution of the motor block; a score of 2 in the 3-point modified Bromage score 2. The duration of sensory blockade is defined as the time between block completion (withdrawal of block needle) and resolution of sensory block (Temperature) at the dermatomal level of C5). 3. Sensory block onset (time between block completion and sensory block (Temperature) at the dermatomal level of C5). 4. Motor block onset (time between block completion and achieving score of 1 in 3-point modified Bromage Scale); Timepoint:

Countries

India

Contacts

Public ContactPravin K

AIIMS Guwahati

bheemas4atlapure@gmail.com9901127633

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026